BridgeBio's comprehensive launch strategy, including patient support programs and a simplified prescription process, addresses key barriers to adoption that have hindered other rare disease treatments. The company's "white glove service" approach and partnerships with high-performing specialty pharmacies could lead to higher conversion rates and patient adherence, driving sustained revenue growth.